Please use this identifier to cite or link to this item:
https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/41
Title: | Recovery from acute haemorrhagic leucoencephalitis secondary to COVID-19. |
Authors: | Bunting, N. Martynoga, R. Crayton, H. Pandita, A. |
MNCLHD Author: | Bunting, Nicholas |
Issue Date: | Aug-2024 |
Citation: | BMJ Case Reports. 2024 Aug 8;17(8). pii: e256640. |
Abstract: | A man in his 50s presented with sudden onset expressive aphasia and right-sided facial droop after experiencing coryzal symptoms and malaise for 7 days prior to admission. A brain MRI showed a rapidly progressive mass effect across both hemispheres and cerebrospinal fluid analysis revealed neutrophil predominance with raised protein levels. Acute disseminated encephalomyelitis was provisionally diagnosed, and high-dose methylprednisone was initiated.On admission to the high dependency unit, the patient tested positive for COVID-19 and was treated with appropriate therapeutic agents for severe COVID-19. A subsequent brain biopsy confirmed a demyelinating process, strongly indicating a diagnosis of acute haemorrhagic leucoencephalitis when correlated with the presence of severe oedema on imaging. Nine sessions of plasma exchange were provided over 18 days.At the time of writing, the patient has made an excellent recovery. We urge clinicians to consider this diagnosis and these treatment options for an otherwise devastating condition. |
URI: | https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/41 |
Appears in Collections: | Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.